Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20260 analyst targets · 90 days
- Share price
- $1.75
- Average 1Y price target
- $3.00+71.43%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall2
- DCF3
- Return on equity1
- Return on assets1
- Debt / equity3
- P/E1
- P/B5
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 0 | — |
| Last quarter | 0 | — |
| Last year | 12 | $12.00 |
| All time | 14 | $12.79 |
Recent rating changes
The latest 27 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 9, 2026 | Citizens | maintain | Market Perform | Market Perform |
| Sep 8, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Jun 18, 2026 | Morgan Stanley | downgrade | Equal Weight | Underweight |
| Jun 16, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 14, 2026 | UBS | maintain | Neutral | Neutral |
| May 8, 2026 | Wells Fargo | downgrade | Overweight | Equal Weight |
| May 8, 2026 | Piper Sandler | downgrade | Overweight | Neutral |
| May 8, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 8, 2026 | Guggenheim | downgrade | Buy | Neutral |
| May 8, 2026 | Citizens | downgrade | Market Outperform | Market Perform |
| Mar 11, 2026 | Oppenheimer | maintain | Outperform | Outperform |
| Mar 9, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Nov 12, 2025 | UBS | maintain | Neutral | Neutral |
| Nov 12, 2025 | Oppenheimer | maintain | Outperform | Outperform |
| Nov 12, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Nov 12, 2025 | Citizens | maintain | Market Outperform | Market Outperform |
| Sep 12, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Sep 12, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 8, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Apr 29, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Mar 11, 2025 | Morgan Stanley | maintain | Overweight | Overweight |
| Mar 11, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Feb 14, 2025 | UBS | downgrade | Buy | Neutral |
| Dec 23, 2024 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Dec 6, 2024 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Sep 24, 2024 | Oppenheimer | maintain | Outperform | Outperform |
| Sep 11, 2024 | Morgan Stanley | maintain | Overweight | Overweight |